Inspire Medical Systems, Inc. to Present at 43rd Annual J.P. Morgan Healthcare Conference
Inspire Medical Systems, Inc. to Present at 43rd Annual J.P. Morgan Healthcare Conference
MINNEAPOLIS, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025.
明尼阿波利斯，2024年12月30日（环球新闻社）——Inspire Medical Systems, Inc.（纽交所：INSP）（Inspire）是一家专注于为患有阻塞性睡眠呼吸暂停的患者开发和商业化创新微创解决方案的医疗科技公司，今天宣布其管理团队将于2025年1月13日（星期一）在第43届摩根大通医疗健康大会上进行演讲。
Inspire is scheduled to present at 11:15 a.m. Eastern Time. The presentation will be accessible via a live webcast here.
Inspire定于东部时间上午11:15进行演讲。您可以通过此处的直播网络广播访问演讲。
Webcast replays of the presentations will be available for two weeks following the presentations in the Event Archive section of Inspire's Investor website at .
演讲的网络广播重播将在演讲后两周内在Inspire的投资者网站的活动存档部分提供。
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology of its kind that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
关于inspire 医疗系统
Inspire是一家专注于为患有阻塞性睡眠呼吸暂停的患者开发和商业化创新微创解决方案的医疗科技公司。Inspire专有的Inspire疗法是首个也是唯一一个获得FDA、欧盟医疗器械法规（EU MDR）和药品市场管理局（PDMA）批准的神经刺激技术，提供安全有效的中度至重度阻塞性睡眠呼吸暂停的治疗。
For additional information about Inspire, please visit .
有关Inspire的更多信息，请访问。
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
投资者和媒体联系方式
Ezgi Yagci
副总裁，投资者关系
ezgiyagci@inspiresleep.com
617-549-2443
